Moors & Cabot, Inc. Abb Vie Inc. Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 64,926 shares of ABBV stock, worth $11.7 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

64,926

Previous 67,609 3.97%

Holding current value

$11.7 Million

Previous $11.6 Million 10.56%

% of portfolio

0.65%

Previous 0.63%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$163.84 - $199.33 $439,582 - $534,802	-2,683 Reduced 3.97%	64,926 $12.8 Million
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $495,947 - $579,155	-3,204 Reduced 4.52%	67,609 $11.6 Million
Q1 2024 May 08, 2024	BUY	$159.82 - $182.1 $22,374 - $25,494	140 Added 0.2%	70,813 $12.9 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $168,284 - $189,528	-1,223 Reduced 1.7%	70,673 $11 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $338,517 - $391,883	2,534 Added 3.65%	71,896 $10.7 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $263,429 - $327,821	-1,988 Reduced 2.79%	69,362 $9.35 Million
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $9,978 - $11,491	69 Added 0.1%	71,350 $11.4 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $568,315 - $681,559	-4,109 Reduced 5.45%	71,281 $11.5 Million
Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $555,176 - $665,802	4,014 Added 5.62%	75,390 $12.2 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $198,630 - $227,816	-1,480 Reduced 2.03%	71,376 $9.58 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $262,028 - $333,123	-1,904 Reduced 2.55%	72,856 $11.2 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $431,442 - $535,298	-3,269 Reduced 4.19%	74,760 $12.1 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $302,522 - $382,778	2,816 Added 3.74%	78,029 $10.6 Million
Q3 2021 Dec 08, 2021	BUY	$106.4 - $120.78 $8 Million - $9.08 Million	75,213 New	75,213 $8.13 Million
Q3 2021 Nov 05, 2021	SELL	$106.4 - $120.78 $7.22 Million - $8.2 Million	-67,862 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $56,392 - $62,824	536 Added 0.8%	67,862 $7.64 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $419,532 - $461,854	4,101 Added 6.49%	67,326 $7.29 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $502,499 - $678,426	6,243 Added 10.96%	63,225 $6.78 Million
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $489,343 - $574,327	5,696 Added 11.11%	56,982 $4.99 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $579,402 - $775,327	7,897 Added 18.2%	51,286 $5.04 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $65,661 - $99,550	1,018 Added 2.4%	43,389 $3.3 Million
Q4 2019 Jan 28, 2020	SELL	$72.13 - $90.25 $15,724 - $19,674	-218 Reduced 0.51%	42,371 $3.75 Million
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $438,340 - $527,011	6,960 Added 19.53%	42,589 $3.23 Million
Q2 2019 Jul 18, 2019	BUY	$65.7 - $83.98 $112,741 - $144,109	1,716 Added 5.06%	35,629 $2.6 Million
Q1 2019 May 06, 2019	SELL	$77.14 - $90.79 $2.62 Million - $3.08 Million	-33,913 Reduced 50.0%	33,913 $2.73 Million
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $2.32 Million - $2.74 Million	30,125 Added 79.91%	67,826 $5.45 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $1.13 Million - $1.39 Million	-14,488 Reduced 27.76%	37,701 $3.47 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $157,904 - $175,539	1,776 Added 3.52%	52,189 $4.93 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $206,583 - $244,435	-2,301 Reduced 4.37%	50,413 $4.67 Million
Q1 2018 May 18, 2018	BUY	$92.01 - $123.21 $219,719 - $294,225	2,388 Added 4.75%	52,714 $4.99 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $205,361 - $225,195	2,293 Added 4.77%	50,326 $4.87 Million
Q3 2017 Nov 16, 2017	BUY	$69.85 - $89.22 $1.31 Million - $1.67 Million	18,697 Added 63.73%	48,033 $4.27 Million
Q2 2017 Aug 15, 2017	BUY	N/A	29,336	29,336 $2.13 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account